Discover the future of treating urge urinary incontinence (UUI) with the innovative Altaviva™ System by Medtronic—an FDA-approved, minimally invasive implantable tibial neuromodulation device designed for long-term symptom relief.

In this episode of UroNurse News, hosted by Vic Senese, RN, BSN, FAUNA, we are joined by expert Dr. Xavier to break down everything healthcare professionals and patients need to know about this cutting-edge therapy.

🔍 What You’ll Learn in This Video:

What is the Altaviva™ System and how does it work?
How tibial neuromodulation targets bladder control pathways
Key benefits vs. traditional treatments like medications and PTNS
Patient selection: Who is the ideal candidate?
Procedure overview: What to expect before, during, and after implantation
Clinical outcomes and long-term effectiveness for UUI

Urge urinary incontinence affects millions, and advancements like implantable tibial neuromodulation are changing the landscape of bladder care. Whether you're a urology nurse, healthcare provider, or someone seeking new treatment options, this episode delivers expert insights you can trust.

💡 Stay ahead in urologic care with the latest innovations and evidence-based education from UroNurse.

👉 Subscribe to my channel: https://www.youtube.com/@UroNurse1
Get weekly updates on urology news, patient education, and clinical breakthroughs!

#UroNurse #UrgeIncontinence #Medtronic #Neuromodulation #UUI #BladderHealth #UrologyNurse #MedicalInnovation #TibialNeuromodulation #ContinenceCare

The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions.

(Audio) Medtronic Altaviva™ Explained: Breakthrough for Urge Incontinence

UroNurse